Home
Market News
Breaking stock market headlines
Earnings Flash
Breaking coverage of earnings reports, forecasts & dividend updates
Trends
Market movers, trading patterns & key market indicators
Disclosures
Official filings & reports from listed Japanese companies
Explorer
Stock lists filtered by fundamental & technical metrics
ASAHI KOGYOSHA, Last Fiscal Year Ordinary Profit Revised Upward by 12%, Raises Record High Profit Forecast, Dividend Revised Upward by 10 yen
1975 ASAHI KOGYOSHA CO.,LTD. 【J-GAAP】
Guidance Update ReportASAHI KOGYOSHA CO.,LTD. <1975> [TSE Prime] announced a revision to its performance and dividend after the market closed on April 25th (16:00). The consolidated ordinary profit for the fiscal year ending March 2025 has been revised upward 11.9%, from the previous forecast of 6.7 billion yen to 7.5 billion yen (compared to 4.89 billion yen in the previous period), increasing the growth rate from 36.8% to 53.2%, further surpassing the previous forecast of record-high profits for two consecutive terms.
Based on the upwardly revised full-year plan announced by the company, our calculation indicates that the October to March period (2H) consolidated ordinary profit is expected to increase 21.7%, from the previous forecast of 3.69 billion yen to 4.49 billion yen (compared to 2.5 billion yen in the same period of the previous year), increasing the growth rate from 47.6% to 79.6%.
In light of the strong performance, the company has increased its planned annual dividend for the last fiscal year from the original plan of 110 yen to 120 yen (compared to 120 yen before the 2-for-1 forward stock split in the previous period).
Kabutan News
Guidance Update
Second Half Update
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Oct - Mar, 2024 Prev | 49,498 | 3,603 | 3,691 | 3,138 | 121.8 | 85 | Feb 6, 2025 | J-GAAP |
Oct - Mar, 2024 New | 51,298 | 4,403 | 4,491 | 3,838 | 149.1 | 95 | Apr 25, 2025 | J-GAAP |
Revision Rate | +3.6% | +22.2% | +21.7% | +22.3% | +22.3% |
Full Year Update
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Mar, 2025 Prev | 90,000 | 6,400 | 6,700 | 5,500 | 213.6 | 110 | Feb 6, 2025 | J-GAAP |
Mar, 2025 New | 91,800 | 7,200 | 7,500 | 6,200 | 240.8 | 120 | Apr 25, 2025 | J-GAAP |
Revision Rate | +2.0% | +12.5% | +11.9% | +12.7% | +12.8% |
Current Period Guidance
Second Half Results
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Oct - Mar, 2023 | 49,679 | 2,357 | 2,501 | 2,097 | 81.6 | 40 | May 15, 2024 | J-GAAP |
Oct - Mar, 2024 Guidance | 51,298 | 4,403 | 4,491 | 3,838 | 149.1 | 95 | Apr 25, 2025 | J-GAAP |
YoY | +3.3% | +86.8% | +79.6% | +83.0% | +82.8% |
Current Period Guidance
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Mar, 2023 | 80,171 | 2,697 | 3,127 | 2,480 | 96.6 | 40 | May 12, 2023 | J-GAAP |
Mar, 2024 | 91,676 | 4,568 | 4,896 | 3,712 | 144.4 | 60 | May 15, 2024 | J-GAAP |
Mar, 2025 Guidance | 91,800 | 7,200 | 7,500 | 6,200 | 240.8 | 120 | Apr 25, 2025 | J-GAAP |
YoY | +0.1% | +57.6% | +53.2% | +67.0% | +66.8% |
Related Articles
MIKUNI, Last Fiscal Year Ordinary Profit Revised Upward by 45%
JAPAN PURE CHEMICAL, 2% Increase in Ordinary Profit for The Current Fiscal Year
KOKUYO, Jan-Mar (1Q) Ordinary Profit Increases by 4%
HORAI, First Half Ordinary Profit Decreases by 34%, Jan-Mar Ordinary Profit Decreases by 41%
Daito Chemix, Last Fiscal Year Net Income Revised Upward by 2.4 times, Dividend Revised Upward by 6 yen
ALMETAX MANUFACTURING, Last Fiscal Year Ordinary Profit Revised Downward to a Loss
NITTO DENKO, 9% Decrease in Net Income for The Current Fiscal Year, Dividend Effectively Increased
WAKAMOTO PHARMA, Last Fiscal Year's Undisclosed Ordinary Loss to Widen
DAIREI, Last Fiscal Year Net Income Revised Downward to a Loss
NIPPON RIETEC, Last Fiscal Year Ordinary Profit Revised Upward by 29%